fda banning compounded tirzepatide confirms shortage is still over, gives compounders a grace period FDA bans compounded GLP1 medications,

Cover Image Credit: Bowie15 / 123RF.com (Licensed)

It also flags light, especially ultraviolet radiation, as something that breaks down semaglutide's chemical structure, along with humidity and air exposure

Why do people switch between GLP-1 medications

A putative class action lawsuit is targeting a GLP-1 supplement that claims to support the bodys GLP-1 production, as well as improve other parameters of weight management like reducing fat and hunger

Front Pharmacol 14:975880 Tanaka T, Nangaku M, Nishiyama A (2011) The role of incretins in salt-sensitive hypertension: the potential use of dipeptidyl peptidase-IV inhibitors

A more evidence-based approach is to define a narrow, measurable goal and decide whether GH-axis manipulation is appropriate at all